The British Menopause Society put the seventh edition of Management of the Menopause on sale online on Monday 13 July, giving UK clinicians a fresh reference point just as the society’s June 2026 practice standards pushed diagnosis further toward symptoms rather than blood tests. Edited by Haitham Hamoda, the evidence-based, peer-reviewed handbook sits in the BMS handbook series and is aimed at healthcare professionals working in post-reproductive health.
For patients, the most consequential change is in the diagnostic message. The BMS says that for women aged 45 and over presenting with menopausal symptoms, perimenopause or menopause should generally be considered on symptoms alone, without confirmatory blood tests unless there is uncertainty. If a GP is still asking for routine bloods before talking about treatment, that standard gives patients a direct question: what uncertainty remains, and why are symptoms not enough?
The chapter list shows how far menopause care now reaches beyond hot flushes. It covers physiology and definitions, cardiovascular disease, osteoporosis prevention and management, assessment and investigation of perimenopause and menopause, healthy lifestyle advice, HRT overview, indications, benefits and risks, breast cancer and HRT, cognitive function and dementia, practical prescribing, unscheduled bleeding on HRT, genitourinary symptoms, complementary and alternative medicine, cognitive behavioural therapy, sexual function, androgen therapy, premature ovarian insufficiency and early menopause, contraception in the perimenopause, long-term health conditions, surgical and medical comorbidities, women at increased risk of cancer or after cancer diagnosis, and menopause in the workplace.
That breadth matters in consultation rooms. A woman struggling with bleeding on HRT, vaginal symptoms, loss of libido or questions about contraception is not outside the menopause conversation anymore; those issues are built into the handbook’s structure. The same applies to non-hormonal care, with cognitive behavioural therapy and complementary approaches given their own place rather than being treated as add-ons. If care feels dated, the practical test is simple: ask whether the clinician is working from a pathway that covers unscheduled bleeding on HRT, genitourinary symptoms, and the risks and benefits of treatment rather than only the presence or absence of flushes.
The BMS handbook page names 24 specialist chapter contributors, including Janice Rymer, Heather Currie, Nick Panay, Paula Briggs and Kathy Abernethy, underlining that this is a multi-author clinical reference rather than a single-view commentary. Rymer, the society’s chair, called the handbook “a timely and essential contribution” to supporting proactive health strategies and holistic wellbeing during and after the menopause transition. The society also says its Management of the Menopause Certificate is designed to give eligible healthcare professionals enough knowledge to treat about 95% of patients in routine menopause care, leaving the most complex cases for specialist referral. Amazon and other booksellers list the seventh edition as a 310-page paperback published on 25 June 2026 with ISBN-13 978-1036955960, and the release sat alongside the BMS 35th Annual Scientific Conference on demand package, which runs from 7 July to 7 October 2026.
